Table 3

Rating of measurement properties

PROMAuthor (year)Structural validityInternal consistencyReliabilityMeasurement errorHypothesis testingCross-cultural validityCriterion validityResponsiveness
CCEQ financial advice domainHarley29 2019
(no data)
+
(Cronbach’s α=0.71–0.88)
NRNR+
(r=0.35–0.39)
NRNRNR
COST-v1De Souza12 2014;
De Souza27 2017
NR+
(Cronbach’s α=0.92)
+
(ICC=0.80)
NR+
(r=0.20–0.42)
NRNRNR
COST-v1, Australia versionDurber28 2021NR+
(Cronbach’s α=0.89)
+
(ICC=0.80)
NR+
(r=-0.39–0.52)
NRNRNR
COST-v1, Brazilian versionde Alcantara Nogueira32 2020- (RMSEA=1.20)+
(Cronbach’s α=0.83)
NRNRNR
(p<0.01)
NRNR
COST-v1, India versionDar25 2021
(EFA: χ2=60.82)
?
(Cronbach’s α=0.92)
NRNRNRNRNRNR
COST-v1 Simplified Chinese versionYu39 2021
(CFI=0.86; SRMR=0.08)
+
(Cronbach’s α=0.85–0.88)
+
(ICC=0.85)
NR+
(r=-0.57–0.88)
NRNR?
(no clear hypothesis)
COST-v2, Italian versionRipamonti33 2020?
(CFI=1.00; RMSEA=0.04)
?
(Cronbach’s α=0.83)
+
(ICC=0.79)
NR+
(r=-0.66–0.15)
NR+
(β=−0.55)
NR
COST-v2, Persian versionSharif34 2020+
(CFI=0.97; RMSEA=0.07)
+
(Cronbach’s α=0.89)
NRNR?
(no clear hypothesis)
NRNRNR
COST-v2, Traditional Chinese versionChan24 2021
(CFI=0.91; RMSEA=0.15)
+
(Cronbach’s α=0.86)
+
(ICC=0.71)
NR+
(r=-0.46–0.47)
NRNRNR
CPILS employment/financial domainZhao41 2009
(EFA: no model data)
+
(Cronbach’s α=0.78–0.97)
NRNR?
(no clear hypothesis)
NRNRNR
FITHueniken31 2020
(EFA: no model data)
+
(Cronbach’s α=0.77)
+
(ICC=0.70)
NR+
(r=0.26–0.61)
NRNR+
(r=−0.25)
IOC-CS financial problems domainZebrack40 2010
(EFA: no model data)

(Cronbach’s α=0.70–0.86)

(ICC ≥0.75)
NR
(>75% were not significant)
NR?
(no data)
NR
PFBVeenstra37 2014
(CFA: no model data)
+
(Cronbach’s α=0.79)
NRNRNRNRNRNR
PROFFITRiva42 2021
(EFA: no model data)
+
(Cronbach’s α=0.87)
+
(ICC=0.80)
NRNRNRNRNR
PRRS financial well-being domainShilling35 2018
(EFA: no model data)
+
(Cronbach’s α=0.90)
+
(ICC=0.86)
NR+
(r=-0.71–0.65)
NR+
(r=−0.65)
NR
P-SAFE, French VersionTremblay36 2020NRNRNRNRNR?
(no data)
NRNR
QLACS financial problems domainAvis23 2005
(CFA: no model data)
+
(Cronbach’s α=0.72)
NRNR+
(r=-0.57–0.60)
NR
(r=−0.72)
NR
SDI-16 money matters domainWright16 2011
(EFA: no model data)
+
(Cronbach’s α=0.71–0.82)
NRNRNRNRNRNR
SDI-21 providing for the family domainWright38 2005
(EFA: no model data)
+
(Cronbach’s α=0.50–0.86)

(Weighted kappa=0.54–0.80)
NR
(33% were not significant)
NR?
(r=−0.72)
NR
SFDQDar25 2021+
(CFI=0.98, TLI=0.97, RMSEA=0.045, SRMR=0.014)
+
(Cronbach’s α=0.85–0.88)
NRNRNRNRNRNR
SWBSHead14 2008
(CFA: no model data)
+
(Cronbach’s α=0.92)
NRNR+
(r=-0.57–0.60)
NR+
(r=-0.12–0.03)
NR
  • CCEQ, Chronic Cancer Experiences Questionnaire; CFA, Confirmatory Factor Analysis; CFI, Comparative Fit Index; COST, Comprehensive Score for Financial Toxicity; CPILS, Cancer Problems in Living Scale; EFA, Exploratory Factor Analysis; FIT, Financial Index of Toxicity; ICC, Intraclass Correlation Coefficient; IOC-CS, Impact of Cancer-Childhood Survivors; NA, not applicable; NR, not report; PFB, Personal Financial Burden ; PROFFIT, Patient-Reported Outcome for Fighting Financial Toxicity; PROM, patient-reported outcome measures; PRRS, Patient Roles and Responsibilities Scale ; P-SAFE, Patient Self-Administered Financial Effects questionnaire; QLACS, Quality of Life in Adult Cancer Survivors; RMSEA, Root Mean Square Error of Approximation; SDI, Social Difficulties Inventory Cancer Care Outcomes; SFDQ, Subjective Financial Distress Questionnaire; SRMR, Standardized Root Mean Square Residual; SWBS, Socioeconomic Well-being Scale.